Cancer Immunotherapy: The way to the Nobel Prize in Medicine
The Nobel Prize organisation. The Nobel Prize 2018. (Accessed October 2018, 1, at https://www.nobelprize.org/prizes/).
IREG. IREG Observatory on Academic Ranking and Excellence 2018. (Accessed October 2018, 1, at http://ireg-observatory.org/en/initiatives).
The Nobel Prize organisation. The Nobel Prize in Physiology or Medicine 2018. (Accessed October 2018, 1, at https://www.nobelprize.org/prizes/medicine/ 2018/summary/).
Hammerich L, Binder A, Brody JD. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf. Mol Oncol 2015;9:1966-81.
Alison JP. The University of Texas MD Anderson Cancer Center 2018. (Accessed October 2018, 1, at https://faculty.mdanderson.org/profiles/james_allison.html).
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
Ledford H, Else H, Warren M. Cancer immunologists scoop medicine Nobel prize. Nature 2018;562:20-1.
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443-54.
Larkin J, Hodi FS, Wolchok JD. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 2015;373:1270-1.
Sriratana P, Norton J. New Immunotherapies in Oncology Treatment and Their Side Effect Profiles. J Am Board Fam Med 2018;31:620-7.
Wills B, Brahmer JR, Naidoo J. Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer. Curr Treat Options Oncol 2018;19:46.
Honjo T. Biography 2018. (Accessed October 2018, 1, at http://www.wcp2018.org/program/bio/Tasuku_ Honjo.html).